Researchers in Japan have developed a new antibody treatment, named H2Mab-250, aimed at fighting HER2-positive breast cancer, a type of cancer characterized by high...
The debate around the optimal strategy for breast cancer screening—concerning both the age at which women should begin screening and the frequency of these...
Positron Emission Tomography (PET) is becoming an increasingly important tool in managing breast cancer.
This shift is largely due to more PET radiotracers being...
Imagine a future where doctors can predict the course of breast cancer with unprecedented accuracy, leading to personalized treatment plans that offer the best...
A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims...